Sources | Names Used |
---|---|
GDSC1000, GRAY, FIMM | Bortezomib |
gCSI, CTRPv2 | bortezomib |
PharmacoGx | Bortezomib |
Database | Identifier |
---|---|
Smiles: | B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O |
Inchikey: | GXJABQQUPOEUTA-RDJZCZTQSA-N |
Pubchem: | 387447 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ELF5 | FIMM | pan-cancer | AAC | -0.44 | 0.002 |
mRNA | TDP2 | gCSI | pan-cancer | AAC | -0.19 | 0.002 |
mRNA | EFEMP1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | USP49 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | PROP1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | SEMA3C | GDSC1000 | pan-cancer | AAC | 0.18 | 0.002 |
mRNA | PTK7 | gCSI | pan-cancer | AAC | 0.22 | 0.002 |
mRNA | IL27RA | gCSI | pan-cancer | AAC | 0.18 | 0.002 |
mRNA | TALDO1 | gCSI | pan-cancer | AAC | -0.18 | 0.002 |
mRNA | KLC3 | gCSI | pan-cancer | AAC | 0.2 | 0.002 |